These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy. Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603 [TBL] [Abstract][Full Text] [Related]
7. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy. Chandorkar AG; Burte NP; Gade RK; Bulakh PM Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381 [TBL] [Abstract][Full Text] [Related]
9. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy. Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585 [No Abstract] [Full Text] [Related]
10. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy. Reyes-Javier PD; Tantiongco PR Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801 [No Abstract] [Full Text] [Related]
11. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy]. Li WZ Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697 [No Abstract] [Full Text] [Related]
15. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients. Mendis S; Somasiri KG; Chularatna W Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332 [TBL] [Abstract][Full Text] [Related]
16. Comparison of two multidrug regimens in multibacillary leprosy. Jadhav VH; Patki AH; Mehta JM Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526 [TBL] [Abstract][Full Text] [Related]
17. Experimental and clinical studies on rifampicin in treatment of leprosy. Rees RJ; Pearson JM; Waters MF Br Med J; 1970 Jan; 1(5688):89-92. PubMed ID: 4903972 [TBL] [Abstract][Full Text] [Related]
18. Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment. Warndorff van Diepen T; Mengistu G Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):189-97. PubMed ID: 2410520 [TBL] [Abstract][Full Text] [Related]
19. Effect of single dose (1500 mg) rifampicin on infectivity of patients with lepromatous leprosy. Girdhar BK; Sreevatsa ; Desikan KV Lepr India; 1980 Jul; 52(3):359-65. PubMed ID: 7206633 [TBL] [Abstract][Full Text] [Related]
20. [2 cases of paucibacillary leprosy resistant to dapsone]. Janssens L Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]